EURODOPPS血液透析患者指南目标达标情况:差异是否与一国医疗支出和肾科医生人力相关?
基于EURODOPPS前瞻性队列中2009至2011年七个欧洲国家6317例成人中心血液透析患者,评估贫血、血脂异常、代谢性酸中毒和矿物质骨病指南目标达标率。仅34.1%达标血压、31.2%达标血红蛋白,仅5%达标全部研究目标;国家间差异明显,但医疗支出和肾科医生人力与达标或不当护理不相关(贫血除外)。
要点
- 仅34.1%患者达到目标血压,31.2%达到目标血红蛋白水平。
- 仅5%患者达到所有研究的指南目标。
- 国家间指南应用和药物使用差异明显,但未发现与宏观经济决定因素相关。
核心结论
- EURODOPPS数据分析显示欧洲整体指南目标达标率低且国家间差异大,这些差异似乎与宏观经济决定因素无关。
研究设计与样本
- EURODOPPS是一项国际前瞻性研究的欧洲部分,为成人中心血液透析患者队列。
- 纳入2009年至2011年七个欧洲国家的6317例患者。
- 从患者记录提取实验室检查和药物处方数据,从世界卫生组织数据库和世界银行统计收集宏观经济指数。
主要发现
- 国际指南目标达标远未完成:仅34.1%患者达到目标血压,31.2%达到目标血红蛋白水平。
- 总体仅5%患者达到所有研究的指南目标。
- 观察到国家间指南采纳/应用水平和药物使用存在明显差异。
- 国家医疗支出水平和肾科医生人力与≥50%研究变量达标患者百分比或不当护理不相关(贫血除外)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the field of chronic kidney disease, global clinical practice guidelines have been developed and implemented with a view to improving patient care and outcomes. The attainment of international and European guideline targets for haemodialysis patients in European countries has not been audited recently. Hence, we sought to establish whether the attainment of the targets set out in guidelines and inappropriate care are similar across European countries and whether inter-country differences are related to disparities in national healthcare expenditures (as a percentage of gross domestic product) and/or the nephrologist workforce per capita. METHODS: EURODOPPS is the European part of an international, prospective study of a cohort of adult, in-centre, haemodialysed patients. For the current project, 6317 patients from seven European countries were included between 2009 and 2011. Data on laboratory test results and medication prescriptions were extracted from patient records, in order to determine the overall percentage of patients treated according to the international guidelines on anaemia, dyslipidaemia, metabolic acidosis and mineral bone disease. Data related to macroeconomic indices were collected from World Health Organization database and World Bank stats. RESULTS: Attainment of the targets set in international guidelines was far from complete; only 34.1% of patients attained their target blood pressure and 31.2% attained their target haemoglobin level. Overall, only 5% of the patients attained all of the studied guideline targets. We observed marked inter-country differences in levels of guideline uptake/application and the use of pharmacological agents. The levels of national healthcare expenditures and nephrologist workforce were not correlated with the percentage of patients on-target for ≥50% of the studied variables or with inappropriate care (except for anaemia). CONCLUSIONS: Our analysis of EURODOPPS data highlighted a low overall level of guideline target attainment in Europe and substantial differences between European countries. These inter-country differences did not appear to be linked to macroeconomic determinants.
引用
- Liabeuf S, Van Stralen KJ, Caskey F, et al. Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce? Nephrol Dial Transplant. 2017. PMID: 28057873. doi:10.1093/ndt/gfw409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。